Данные достижения подчеркивают клинический прогресс и укрепляют коммерческую основу ЛОС-ГАТОС, шт. Калифорния, 9 апреля 2026 г. /PRNewswire/ -- Supira Medical, Inc. (Supira), компания клинической стадии исследований, ориентированная на трансформацию рынка чрескожных желудочковых...
Hence then, the article about supira medical obyavlyaet ob odobrenii fda bazovogo issledovaniya support ii dostizheniyah v oblasti kardiogennogo shoka i naznachenii d kita grossmana d keith grossman v sovet direktorov was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Supira Medical объявляет об одобрении FDA базового исследования SUPPORT II, достижениях в области кардиогенного шока и назначении Д. Кита Гроссмана (D. Keith Grossman) в Совет директоров )
Also on site :
- Nancy Guthrie News: Detective Worries She Had Medical Emergency During Kidnapping Ordeal
- Paris’ Eeriest Attraction Finally Reopens After Being Shut Down for 5 Months— Here’s What Tourists Need To Know
- 'The Boys' Creator Eric Kripke Explains That Shocking Premiere Death: 'It Was Time' (Exclusive)